FindTrial
Sign In

The antiemetic efficacy and safety of subhypnotic dose of propofol for decreasing the incidence of intraoperative nausea and vomiting during cesarean section

The antiemetic efficacy and safety of subhypnotic dose of propofol for decreasing the incidence of intraoperative nausea and vomiting during cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009539
Enrollment
Unknown
Registered
2016-10-21
Start date
2016-10-20
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting

Interventions

placebo:normal saline
propofol intervention group:propofol

Sponsors

Aviation General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. ASA I-II; 2. elective caesarean section; 3. gestation period=37 weeks; 4. breast feeding.

Exclusion criteria

Exclusion criteria: 1. who had gastrointestinal diseases; 2. who had history of motion sickness and/or previous emesis 24 hours before surgery; 3. who are allergic to propofol; 4. whose body weight two times than normal; 5. who had a history of emesisi in an intraoperative, post-delivery period; 6. who had received any antiemetic medication within 24 hours before surgery.

Design outcomes

Primary

MeasureTime frame
The intensity of nausea;sedation scores;times of retching;times of vomiting;times of rescue;Satisfaction;Total dose of propofol;period of surgery;—

Secondary

MeasureTime frame
Intraoperative application of drugs;based blood pressure;based heart rate;oxyhemoglobin saturation;phenylephrine;—

Countries

China

Contacts

Public ContactJianxiong An

Aviation General Hospital

anjianxiong@yeah.net+86 13801281750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026